| IDa | Primary IDb | SAGE library | Sample | Clusterc | Sumd | Averagee | Maxf |
| Top 10% libraries |
| 76 | 301 | GSM125353 | Bronchial brushings, former smoker | N | 43,563.92 | 251.81 | 40,054.67 | 4 | 6 | GSM574 | Central retina (macula) | N | 33,159.24 | 191.67 | 26,692.01 | 142 | 427 | GSM383793 | Mammary gland, ductal carcinoma in situ | C | 29,781.50 | 172.15 | 25,275.20 | 29 | 104 | GSM1730 | Breast, ductal carcinoma in situ | C | 29,575.98 | 170.96 | 25,125.63 | 75 | 300 | GSM125352 | Bronchial brushings, former smoker | N | 29,184.64 | 168.70 | 24,955.09 | 145 | 430 | GSM383797 | Mammary gland, ductal carcinoma | C | 27,222.30 | 157.35 | 22,422.27 | 99 | 346 | GSM194651 | Oral biopsy | N | 27,066.16 | 156.45 | 21,312.29 | 90 | 273 | GSM112808 | Neuroblastoma, primary tumor, stage 4S | C | 25,944.14 | 149.97 | 17,365.83 | 55 | 155 | GSM14753 | Breast carcinoma metastasis to lung | C | 23,941.22 | 138.39 | 20,247.08 | 143 | 428 | GSM383794 | Mammary gland, ductal carcinoma in situ | C | 23,570.83 | 136.25 | 18,977.90 | 30 | 105 | GSM1731 | Breast, ductal carcinoma in situ | C | 23,346.84 | 134.95 | 18,746.14 | 167 | 507 | GSM383893 | Gallbladder tubular adenocarcinoma | C | 23,262.07 | 134.46 | 20,154.48 | 27 | 561 | GSM384016 | Vascular endothelium, hemangioma, benign hyperplasia | D | 22,688.19 | 131.15 | 12,514.88 | 91 | 274 | GSM112809 | Neuroblastoma, primary tumor, stage 4S | C | 22,633.99 | 130.83 | 11,595.94 | 28 | 101 | GSM1516 | Hemangioma tumor | C | 22,622.41 | 130.77 | 12,500.82 | 100 | 347 | GSM194652 | Oral biopsy | N | 21,279.52 | 123.00 | 11,932.33 | 146 | 440 | GSM383807 | Mammary gland, ductal carcinoma in situ | C | 20,570.15 | 118.90 | 16,071.37 | 62 | 433 | GSM383800 | Breast carcinoma cell line | IV | 20,467.40 | 118.31 | 12,710.80 | 140 | 425 | GSM383790 | Mammary gland, ductal carcinoma | C | 20,417.00 | 118.02 | 15,536.62 | 144 | 537 | GSM383946 | Whole body, fetal | N | 20,274.33 | 117.19 | 9,698.99 | 149 | 443 | GSM383812 | Mammary gland, ductal carcinoma | C | 20,036.49 | 115.82 | 13,377.93 | 5 | 21 | GSM688 | Breast, ductal carcinoma in situ | C | 19,968.16 | 115.42 | 15,538.48 | 118 | 416 | GSM383775 | Cortex, pooled sample | N | 19,926.52 | 115.18 | 13,701.49 | 54 | 263 | GSM85616 | Bronchial epithelium | N | 19,665.60 | 113.67 | 15,918.74 | 53 | 262 | GSM85611 | Bronchial epithelium | N | 19,653.98 | 113.61 | 15,655.95 | 17 | 340 | GSM194386 | Metaplastic bronchial epithelium | D | 19,376.31 | 112.00 | 14,577.13 | 81 | 306 | GSM125358 | Bronchial brushings, never smoker | N | 19,369.05 | 111.96 | 14,172.30 | 137 | 509 | GSM383895 | Gallbladder | N | 19,320.00 | 111.68 | 15,346.14 | 66 | 437 | GSM383804 | Breast carcinoma cell line | IV | 19,247.28 | 111.26 | 9,389.55 | 31 | 106 | GSM1733 | Mammary gland, ductal invasive in situ carcinoma | C | 19,126.03 | 110.56 | 14,594.68 | 92 | 276 | GSM112812 | Neuroblastoma, primary tumor, stage 4 | C | 18,914.78 | 109.33 | 12,349.04 | 3 | 5 | GSM573 | Peripheral retina | N | 18,817.72 | 108.77 | 12,293.99 | 2 | 4 | GSM572 | Peripheral retina | N | 18,781.47 | 108.56 | 8,727.76 | 96 | 331 | GSM194377 | Nonsmall cell lung cancer: squamous cell carcinoma in situ | C | 18,122.08 | 104.75 | 14,601.68 | 71 | 181 | GSM14781 | Brain desmoplastic medulloblastoma | C | 18,106.48 | 104.66 | 11,244.70 | 68 | 439 | GSM383806 | Breast carcinoma cell line | IV | 17,991.89 | 104.00 | 8,886.81 | 66 | 291 | GSM125343 | Bronchial brushings, former smoker | N | 17,662.13 | 102.09 | 12,756.35 | 60 | 285 | GSM125337 | Bronchial brushings, current smoker | N | 17,598.56 | 101.73 | 12,699.28 | 121 | 387 | GSM383710 | Ependymoma | C | 17,524.27 | 101.30 | 10,222.49 | 51 | 260 | GSM82458 | Hippocampus | N | 17,289.52 | 99.94 | 8,268.90 | 72 | 297 | GSM125349 | Bronchial brushings, former smoker | N | 17,225.16 | 99.57 | 13,193.26 | 109 | 361 | GSM296391 | Lung biopsy | N | 17,223.67 | 99.56 | 13,839.55 | 62 | 287 | GSM125339 | Bronchial brushings, current smoker | N | 16,871.13 | 97.52 | 10,737.09 | 98 | 333 | GSM194379 | Nonsmall cell lung cancer: squamous cell carcinoma in situ | C | 16,572.81 | 95.80 | 12,713.33 | 74 | 299 | GSM125351 | Bronchial brushings, former smoker | N | 16,456.57 | 95.12 | 11,137.34 | 70 | 295 | GSM125347 | Bronchial brushings, former smoker | N | 16,306.85 | 94.26 | 11,835.62 | 7 | 216 | GSM37212 | Adrenal cortex affected by primary pigmented nodular adrenocortical disease | D | 16,221.46 | 93.77 | 4,205.56 | 59 | 284 | GSM125336 | Bronchial brushings, current smoker | N | 16,090.33 | 93.01 | 11,242.21 | 94 | 329 | GSM194375 | Nonsmall cell lung cancer: squamous cell carcinoma in situ | C | 15,715.04 | 90.84 | 11,679.51 |
| Bottom 10% libraries |
| 83 | 488 | GSM383868 | Colon carcinoma, cell line | IV | 4,179.31 | 24.16 | 422.91 | 38 | 180 | GSM14780 | Gastric epithelial tissue from the antrum | N | 4,169.95 | 24.10 | 1,615.39 | 84 | 204 | GSM14807 | Lung, poorly differentiated adenocarcinoma with lymphoplasmacytic infiltration | C | 4,146.18 | 23.97 | 460.69 | 181 | 553 | GSM383998 | Gastroesophageal junction adenocarcinoma | C | 4,141.08 | 23.94 | 1,351.60 | 1 | 7 | GSM668 | Kidney, embryonic cell line 293, uninduced cells | IV | 4,119.01 | 23.81 | 920.45 | 4 | 120 | GSM3244 | AIDS-KS lesion | D | 4,107.85 | 23.74 | 1,245.47 | 25 | 522 | GSM383914 | Lung, tumor associated (focal fibrosis and chronic inflammation) | D | 4,103.62 | 23.72 | 606.45 | 30 | 121 | GSM3245 | CD4+ T cells | N | 4,088.74 | 23.63 | 978.17 | 44 | 137 | GSM14734 | Medulloblastoma, cerebellum | C | 4,081.98 | 23.60 | 804.90 | 56 | 162 | GSM14760 | Stomach, poorly differentiated carcinoma | C | 4,081.16 | 23.59 | 1,340.95 | 54 | 153 | GSM14751 | Skin, melanoma | C | 4,072.22 | 23.54 | 2,497.12 | 80 | 485 | GSM383865 | Colon carcinoma, cell line | IV | 4,048.02 | 23.40 | 404.80 | 130 | 404 | GSM383753 | Medulloblastoma | C | 3,987.16 | 23.05 | 1,069.73 | 82 | 487 | GSM383867 | Colon carcinoma, cell line | IV | 3,961.32 | 22.90 | 506.24 | 12 | 71 | GSM747 | Colon, cancer cell line | IV | 3,945.42 | 22.81 | 673.61 | 166 | 506 | GSM383892 | Gallbladder adenocarcinoma | C | 3,909.95 | 22.60 | 651.66 | 115 | 372 | GSM311354 | CD15+ myeloid progenitor cells | N | 3,859.27 | 22.31 | 1,108.11 | 52 | 261 | GSM82459 | Spermatozoa | N | 3,814.90 | 22.05 | 1,288.15 | 50 | 259 | GSM82243 | Spermatozoa, pooled sample | N | 3,811.16 | 22.03 | 1,429.18 | 94 | 328 | GSM180670 | Lymphocytes from children 1–4 years old (pooled samples) | N | 3,794.27 | 21.93 | 843.17 | 81 | 486 | GSM383866 | Colon carcinoma, cell line | IV | 3,746.12 | 21.65 | 378.40 | 39 | 183 | GSM14784 | Bone marrow | N | 3,740.58 | 21.62 | 962.65 | 88 | 318 | GSM136195 | Cord blood-derived activated Th1 cells | N | 3,668.81 | 21.21 | 777.29 | 20 | 423 | GSM383787 | Breast stroma, ductal carcinoma in situ associated | D | 3,663.78 | 21.18 | 334.67 | 38 | 234 | GSM66698 | HL-60 cells | IV | 3,661.81 | 21.17 | 920.25 | 168 | 508 | GSM383894 | Gallbladder tubular adenocarcinoma | C | 3,643.40 | 21.06 | 624.22 | 28 | 217 | GSM37337 | Primary bronchial epithelial cells | IV | 3,604.30 | 20.83 | 804.84 | 177 | 546 | GSM383970 | Retinoblastoma | C | 3,561.82 | 20.59 | 384.45 | 71 | 475 | GSM383852 | Cartilage chondrosarcoma cell line | IV | 3,502.94 | 20.25 | 515.14 | 38 | 127 | GSM7800 | Primary gastric cancer, poorly differentiated (scirrhous type) | C | 3,413.27 | 19.73 | 636.37 | 130 | 466 | GSM383840 | Mammary myoepithelium, CD10+ cells | N | 3,364.85 | 19.45 | 291.33 | 39 | 235 | GSM66712 | HL-60 cells exposed to 2.45 GHz radiofrequency for 2 h | IV | 3,293.77 | 19.04 | 982.36 | 97 | 344 | GSM194649 | Oral brushing | N | 3,290.72 | 19.02 | 996.85 | 173 | 523 | GSM383915 | Lymph node, B-cell lymphoma | C | 3,166.97 | 18.31 | 555.61 | 140 | 514 | GSM383902 | Leukocytes | N | 2,991.69 | 17.29 | 439.34 | 65 | 436 | GSM383803 | Breast carcinoma cell line | IV | 2,988.12 | 17.27 | 597.62 | 63 | 434 | GSM383801 | Breast carcinoma cell line | IV | 2,977.71 | 17.21 | 297.77 | 21 | 84 | GSM784 | Gastric epithelial tissues | N | 2,970.06 | 17.17 | 673.21 | 151 | 554 | GSM384002 | Stomach | N | 2,813.83 | 16.26 | 654.38 | 170 | 515 | GSM383903 | Liver cholangiocarcinoma metastasis | C | 2,736.32 | 15.82 | 1,575.46 | 29 | 578 | GSM389908 | Total blood after EPO treatment, pooled sample | D | 2,684.90 | 15.52 | 747.69 | 68 | 175 | GSM14775 | Skin, primary malignant melanoma | C | 2,612.99 | 15.10 | 653.25 | 40 | 236 | GSM66714 | HL-60 cells exposed to 2.45 GHz radiofrequency for 6 h | IV | 1,879.82 | 10.87 | 639.52 | 143 | 533 | GSM383937 | Pancreas | N | 1,813.11 | 10.48 | 278.94 | 83 | 308 | GSM135389 | Skeletal muscle, 5 days training young men | N | 1,673.61 | 9.67 | 435.14 | 86 | 311 | GSM135392 | Skeletal muscle, detraining young men | N | 1,670.43 | 9.66 | 510.41 | 165 | 576 | GSM389906 | Total blood, pooled sample | N | 1,511.12 | 8.73 | 436.55 | 82 | 307 | GSM135388 | Skeletal muscle, pretraining young men | N | 1,091.72 | 6.31 | 327.52 | 28 | 577 | GSM389907 | Total blood during EPO treatment, pooled sample | D | 811.75 | 4.69 | 162.35 |
|
|